Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Samir Mouhssine
Observed names:
Mouhssine, Samir,
S. Mouhssine
Institutions:
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”,
Azienda Ospedaliero Universitaria Maggiore della Carita
Observed institutions:
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”,
Azienda Ospedaliero Universitaria Maggiore della Carita
ORCID:
0000-0002-0389-3268
Observed ORCID:
0000-0002-0389-3268
OpenAlex ID:
A5084053548
Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms
2024
·
Samir Mouhssine
, Nawar Maher
, et al.
·
International Journal of Molecular Sciences
·
49
PDF
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes
2022
·
Marco Gallazzi
, Maghalie Anais Marie Ucciero
, et al.
·
International Journal of Molecular Sciences
·
35
PDF
Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma
2025
·
Riccardo Dondolin
, Federico Garrou
, et al.
·
Leukemia
·
33
PDF
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels
2025
·
Riccardo Moia
, Donatella Talotta
, et al.
·
Blood Advances
·
29
PDF
Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers
2023
·
Nawar Maher
, Samir Mouhssine
, et al.
·
International Journal of Molecular Sciences
·
26
PDF
Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome
2022
·
Chiara Favini
, Donatella Talotta
, et al.
·
British Journal of Haematology
·
26
PDF
Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies
2025
·
Nawar Maher
, Samir Mouhssine
, et al.
·
Cancers
·
24
Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities
2023
·
Anil Babu Payedimarri
, Samir Mouhssine
, et al.
·
BMJ Oncology
·
16
PDF
Richter Syndrome: From Molecular Pathogenesis to Druggable Targets
2022
·
Samir Mouhssine
, Gianluca Gaidano
·
Cancers
·
14
PDF
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation
2026
·
Chiara Cosentino
, Samir Mouhssine
, et al.
·
HemaSphere
·
12
PDF
Current Therapeutic Sequencing in Chronic Lymphocytic Leukemia
2024
·
Samir Mouhssine
, Nawar Maher
, et al.
·
Hematology Reports
·
12
Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy
2023
·
Abdurraouf Mokhtar Mahmoud
, Gianluca Gaidano
, et al.
·
Cancers
·
10
PDF
A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance
2023
·
Samir Mouhssine
, Nawar Maher
, et al.
·
Translational Cancer Research
·
9
PDF
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling
2023
·
Riccardo Moia
, Lodovico Terzi di Bergamo
, et al.
·
British Journal of Haematology
·
9
PDF
Assessing patterns of authorship of low- and middle-income countries in global commercial clinical trials in oncology
2025
·
Anil Babu Payedimarri
, Samir Mouhssine
, et al.
·
Globalization and Health
·
5
PDF
Molecular Pathogenesis and Targeted Treatment of Richter Transformation
2026
·
Nawar Maher
, Amir Karami
, et al.
·
Biomedicines
·
4
PDF
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement
2024
·
Jana Nabki
, Bashar Al Deeban
, et al.
·
Leukemia
·
4
PDF
Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemia
2022
·
Riccardo Moia
, Riccardo Dondolin
, et al.
·
Hematological Oncology
·
4
PDF
Molecular Mechanisms of Resistance to Bispecific Antibodies in Diffuse Large B-Cell Lymphoma
2026
·
Nawar Maher
, Bashar Al Deeban
, et al.
·
Cells
·
3
PDF
Assessing patterns of authorship of low- and middle-income countries in global commercial clinical trials in oncology
2026
·
Payedimarri, Anil Babu
, Mouhssine, Samir
, et al.
·
Figshare
·
1
Feasibility and safety of bispecific antibodies outpatient model in triple-refractory multiple myeloma patients in two Italian centers
2025
·
Paola Boggione
, Gloria Margiotta Casaluci
, et al.
·
Blood
·
1
Dissecting clonal hematopoiesis in diffuse large B-cell lymphoma through multi-compartment genomic profiling
2025
·
Nawar Maher
, Samir Mouhssine
, et al.
·
Blood
·
1
PDF
Prevalence and Clinical Impact of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Chronic Lymphocytic Leukemia and Richter Transformation
2024
·
Chiara Cosentino
, Samir Mouhssine
, et al.
·
Blood
·
1
PDF
Molecular Clustering on Ctdna Improves the Prognostic Stratification of Dlbcl Patients Compared to Ctdna Levels
2023
·
R. Moia
, D. Talotta
, et al.
·
Hematological Oncology
·
1
PDF
Molecular Clustering on Ctdna May Improve Prognostic Stratification of DLBCL Patients
2022
·
Riccardo Moia
, Chiara Favini
, et al.
·
Blood
·
1
Show more works
View as search
Works count:
45
Citation count:
331
H-index:
11
I10-index:
12
Year
Topic
Type